Gonçalo Brites completed his Bsc degree in Biotechnology at Polytechnic Institute of Coimbra- Agricultural College of Coimbra , Portugal (2010-2013). He studied fundamental theoretical concepts in the field of biotechnology, genetics, chemistry and physics.
Gonçalo did voluntary research work in the field of Photodynamic Therapy at the Biophysics Unit of the Faculty of Medicine, University of Coimbra, Portugal.
He completed is Master degree in Pharmaceutical Biotechnology in the Faculty of Pharmacy from the same University (2014-2016). He did his master thesis in the Biophysics Unit of the Faculty of Medicine.
In 2015 he won a research grant supported by Liga Portuguesa Contra o Cancro 2015 (LPCC/ANA).
In 2017 he was a fellowship holder researcher in the the FCT project "Novos Macrociclos Tetrapirrólicos como Eficientes Agentes de Teragnóstico do Cancro", refª PTDC/QEQ-MED/0262/2014 in CQC and Department of Chemistry, University of Coimbra, Biophysics Unit of the Faculty of Medicine , University of Coimbra, Portugal ; CNC.IBILI Consortium, University of Coimbra;
Since 2018, he is doing his PhD in Pharmaceutical Sciences in the Drugs R&D Program in Toxfinder LDA and in the Faculty of Pharmacy in the University of Coimbra and Center for Neuroscience and Cell Biology, Portugal
Gonçalo Brites completed his Bsc degree in Biotechnology at Polytechnic Institute of Coimbra- Agricultural College of Coimbra , Portugal (2010-2013). He studied fundamental theoretical concepts in the field of biotechnology, genetics, chemistry and physics.
Gonçalo did voluntary research work in the field of Photodynamic Therapy at the Biophysics Unit of the Faculty of Medicine, University of Coimbra, Portugal.
He completed is Master degree in Pharmaceutical Biotechnology in the Faculty of Pharmacy from the same University (2014-2016). He did his master thesis in the Biophysics Unit of the Faculty of Medicine.
In 2015 he won a research grant supported by Liga Portuguesa Contra o Cancro 2015 (LPCC/ANA).
In 2017 he was a fellowship holder researcher in the the FCT project "Novos Macrociclos Tetrapirrólicos como Eficientes Agentes de Teragnóstico do Cancro", refª PTDC/QEQ-MED/0262/2014 in CQC and Department of Chemistry, University of Coimbra, Biophysics Unit of the Faculty of Medicine , University of Coimbra, Portugal ; CNC.IBILI Consortium, University of Coimbra;
Since 2018, he is doing his PhD in Pharmaceutical Sciences in the Drugs R&D Program in Toxfinder LDA and in the Faculty of Pharmacy in the University of Coimbra and Center for Neuroscience and Cell Biology, Portugal